Siska Van Bruwaene1, Benjamin Namdarian2, Ben Challacombe2, Ben Eddy3, Ignace Billiet4. 1. AZ Groeninge, P. Kennedylaan 5, 8500, Kortrijk, Belgium. siska.vanbruwaene@gmail.com. 2. Guy's Hospital, Guy's and St Thomas' Trust (GSTT), London, UK. 3. Kent and Canterbury Hospital, East Kent Hospital Trust (EKHUFT), Canterbury, UK. 4. AZ Groeninge, P. Kennedylaan 5, 8500, Kortrijk, Belgium.
Abstract
PURPOSE: Surgical innovation is necessary to ensure continued improvement in patient care. However, several challenges unique to the surgical craft are encountered during the development and validation of such new technology. This article highlights some of these challenges and gives an overview of existing solutions. METHODS: A Pubmed review was performed about the "introduction of new technology" to identify challenges. Cross-referencing was used to explore the possible solutions per challenge. RESULTS: Several characteristics of the surgical craft itself limit our ability to establish randomised controlled trials and hence provide clear categorical evidence. Existing certification bodies for new technology often use unstructured regulations and allow fast-track bypassing systems. Consequently the IDEAL framework (innovation, development, exploration, assessment, long-term follow-up) proposes an objective scientific approach whilst defining stakeholder responsibilities. The selection of which new modality to implement is heavily influenced by third parties unrelated to the best patient outcomes and thus professional organisations can aid in this decision-making. Appropriate training of surgeons and their teams until proficiency is achieved is essential prior to credentialling. Finally long-term surveillance of outcomes in the form of registries is an increasing responsibility of the urological community to maintain our role in directing the adoption or rejection of these innovations. CONCLUSION: Urological innovation is a dynamic and challenging process. Increasing efforts are identified within the urological community to render the process more reliable and transparent.
PURPOSE: Surgical innovation is necessary to ensure continued improvement in patient care. However, several challenges unique to the surgical craft are encountered during the development and validation of such new technology. This article highlights some of these challenges and gives an overview of existing solutions. METHODS: A Pubmed review was performed about the "introduction of new technology" to identify challenges. Cross-referencing was used to explore the possible solutions per challenge. RESULTS: Several characteristics of the surgical craft itself limit our ability to establish randomised controlled trials and hence provide clear categorical evidence. Existing certification bodies for new technology often use unstructured regulations and allow fast-track bypassing systems. Consequently the IDEAL framework (innovation, development, exploration, assessment, long-term follow-up) proposes an objective scientific approach whilst defining stakeholder responsibilities. The selection of which new modality to implement is heavily influenced by third parties unrelated to the best patient outcomes and thus professional organisations can aid in this decision-making. Appropriate training of surgeons and their teams until proficiency is achieved is essential prior to credentialling. Finally long-term surveillance of outcomes in the form of registries is an increasing responsibility of the urological community to maintain our role in directing the adoption or rejection of these innovations. CONCLUSION: Urological innovation is a dynamic and challenging process. Increasing efforts are identified within the urological community to render the process more reliable and transparent.
Entities:
Keywords:
Development; Implementation; Regulation; Surgical innovation; Training
Authors: Oliver T Mytton; Adriana Velazquez; Reiner Banken; Joseph L Mathew; Tuija S Ikonen; Kevin Taylor; Frank Painter; Rachel Jean-Baptiste; Albert Poon; Enrique Ruelas Journal: Qual Saf Health Care Date: 2010-08
Authors: Jeffrey S Barkun; Jeffrey K Aronson; Liane S Feldman; Guy J Maddern; Steven M Strasberg; Douglas G Altman; Jeffrey S Barkun; Jane M Blazeby; Isabell C Boutron; W Bruce Campbell; Pierre-Alain Clavien; Jonathan A Cook; Patrick L Ergina; David R Flum; Paul Glasziou; John C Marshall; Peter McCulloch; Jon Nicholl; Bournaby C Reeves; Christoph M Seiler; Jonathan L Meakins; Deborah Ashby; Nick Black; John Bunker; Martin Burton; Marion Campbell; Kalipso Chalkidou; Iain Chalmers; Marc de Leval; Jon Deeks; Adrian Grant; Muir Gray; Roger Greenhalgh; Milos Jenicek; Sean Kehoe; Richard Lilford; Peter Littlejohns; Yoon Loke; Rajan Madhock; Kim McPherson; Peter Rothwell; Bill Summerskill; David Taggart; Parris Tekkis; Matthew Thompson; Tom Treasure; Ulrich Trohler; Jan Vandenbroucke Journal: Lancet Date: 2009-09-26 Impact factor: 79.321
Authors: Vivian E Strong; Kenneth A Forde; Bruce V MacFadyen; John D Mellinger; Peter F Crookes; Lelan F Sillin; Phillip P Shadduck Journal: Surg Endosc Date: 2014-06-25 Impact factor: 4.584
Authors: Holger Gerullis; Dimitri Barski; Evangelos Georgas; Mihaly Borós; Albert Ramon; Thorsten H Ecke; Silvia Selinski; Dörte Luedders; Mario W Kramer; Alexander Winter; Friedhelm Wawroschek; Thomas Otto Journal: Adv Ther Date: 2017-02-23 Impact factor: 3.845
Authors: Mara Buijs; Krijn P van Lienden; Peter Gk Wagstaff; Matthijs Jv Scheltema; Daniel M de Bruin; Patricia J Zondervan; Otto M van Delden; Ton G van Leeuwen; Jean Jmch de la Rosette; M Pilar Laguna Journal: JMIR Res Protoc Date: 2017-02-16